Category Archives: Global
Roche Ups the Stakes on Personalized Medicine
By Patricia Van Arnum, Pharmaceutical Technology.
Personalized medicine, which targets individualized treatment and care based on personal and genetic variations, holds much promise for the pharmaceutical industry. Several pharmaceutical majors continue to invest in this emerging field as evident by Roche’s $5.7-billion bid last week for Illumina, a provider of gene-sequencing tools and related analytics.
Also posted in Biotech, Europe, Guest Blog Tagged diagnostics, Personalized medicine, Roche Leave a comment
Pharma: Get Ready for the New Supply Chains
New pharma supply chains, where chill control and traceability challenges will be far more critical, will emerge over the next decade, So it’s time, argues Julian Mosquera, for the industry to upgrade its capabilities.
The pharmaceuticals industry is undergoing major disruption and every comparative benchmark indicates that the sector needs to make a step change in [...]
Also posted in Guest Blog, Safety, Supply Chain Tagged chill chain, supply chain management, traceability 1 Comment
Arise Sir Andrew (Witty)
Big Pharma received a nod in the UK’s New Year’s Honours List this week when a knighthood was duly bestowed upon GSK’s Andrew Witty — making him ‘Sir Andrew’ to you and me. For once, though, receiving such an honor did not exactly place him in totally exalted company.
Also posted in Op-Ed, leadership Tagged Andrew Witty, GSK, New Year Honours, UK pharma Leave a comment
Lilly's Decentralized Global Launch Strategy
Global headquarters may get the strategic ball rolling for a new drug launch, but Lilly’s affiliates are responsible for bringing home the bacon, according to a Lilly global brand director.

Unmet Need in the Migraine Space?